Annual Inventory
$3.09 B
+$506.80 M+19.64%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual inventory is $3.09 billion, with the most recent change of +$506.80 million (+19.64%) on December 31, 2024.
- During the last 3 years, REGN annual inventory has risen by +$1.14 billion (+58.22%).
- REGN annual inventory is now at all-time high.
Performance
REGN Inventory Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Inventory
$3.09 B
+$69.30 M+2.30%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly inventory is $3.09 billion, with the most recent change of +$69.30 million (+2.30%) on December 31, 2024.
- Over the past year, REGN quarterly inventory has increased by +$506.80 million (+19.64%).
- REGN quarterly inventory is now at all-time high.
Performance
REGN Quarterly Inventory Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Inventory Formula
Inventory = Beginning Inventory + Purchases − Cost of Goods Sold
REGN Inventory Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.6% | +19.6% |
| 3 y3 years | +58.2% | +19.6% |
| 5 y5 years | +118.1% | +19.6% |
REGN Inventory Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.2% | at high | +58.2% |
| 5 y | 5-year | at high | +118.1% | at high | +118.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Regeneron Pharmaceuticals Inventory History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $3.09 B(+19.6%) | $3.09 B(+2.3%) |
| Sep 2024 | - | $3.02 B(+5.0%) |
| Jun 2024 | - | $2.87 B(+5.8%) |
| Mar 2024 | - | $2.71 B(+5.2%) |
| Dec 2023 | $2.58 B(+7.4%) | $2.58 B(+0.7%) |
| Sep 2023 | - | $2.56 B(+2.2%) |
| Jun 2023 | - | $2.51 B(+3.4%) |
| Mar 2023 | - | $2.42 B(+0.9%) |
| Dec 2022 | $2.40 B(+23.1%) | $2.40 B(-0.4%) |
| Sep 2022 | - | $2.41 B(+8.7%) |
| Jun 2022 | - | $2.22 B(+11.4%) |
| Mar 2022 | - | $1.99 B(+2.1%) |
| Dec 2021 | $1.95 B(+1.8%) | $1.95 B(-5.0%) |
| Sep 2021 | - | $2.05 B(+3.5%) |
| Jun 2021 | - | $1.98 B(-8.4%) |
| Mar 2021 | - | $2.16 B(+12.9%) |
| Dec 2020 | $1.92 B(+35.4%) | $1.92 B(+6.4%) |
| Sep 2020 | - | $1.80 B(+9.8%) |
| Jun 2020 | - | $1.64 B(+10.8%) |
| Mar 2020 | - | $1.48 B(+4.6%) |
| Dec 2019 | $1.42 B(+23.0%) | $1.42 B(+5.3%) |
| Sep 2019 | - | $1.34 B(+2.1%) |
| Jun 2019 | - | $1.32 B(+9.0%) |
| Mar 2019 | - | $1.21 B(+5.0%) |
| Dec 2018 | $1.15 B(+58.5%) | $1.15 B(+10.7%) |
| Sep 2018 | - | $1.04 B(+12.0%) |
| Jun 2018 | - | $928.55 M(+13.2%) |
| Mar 2018 | - | $820.40 M(+13.0%) |
| Dec 2017 | $726.10 M(+81.8%) | $726.10 M(+13.2%) |
| Sep 2017 | - | $641.59 M(+15.7%) |
| Jun 2017 | - | $554.32 M(+18.8%) |
| Mar 2017 | - | $466.58 M(+16.8%) |
| Dec 2016 | $399.36 M(+67.4%) | $399.36 M(+15.5%) |
| Sep 2016 | - | $345.62 M(+9.3%) |
| Jun 2016 | - | $316.07 M(+4.2%) |
| Mar 2016 | - | $303.29 M(+27.1%) |
| Dec 2015 | $238.58 M(+85.1%) | $238.58 M(+25.1%) |
| Sep 2015 | - | $190.67 M(+11.3%) |
| Jun 2015 | - | $171.27 M(+27.9%) |
| Mar 2015 | - | $133.86 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $128.86 M(+83.2%) | $128.86 M(+7.1%) |
| Sep 2014 | - | $120.32 M(+9.5%) |
| Jun 2014 | - | $109.90 M(+27.0%) |
| Mar 2014 | - | $86.55 M(+23.0%) |
| Dec 2013 | $70.35 M(+145.7%) | $70.35 M(+11.2%) |
| Sep 2013 | - | $63.29 M(+10.7%) |
| Jun 2013 | - | $57.16 M(+30.0%) |
| Mar 2013 | - | $43.98 M(+53.6%) |
| Dec 2012 | $28.64 M(+72.4%) | $28.64 M(-3.2%) |
| Sep 2012 | - | $29.57 M(+21.1%) |
| Jun 2012 | - | $24.43 M(+18.5%) |
| Mar 2012 | - | $20.62 M(+24.1%) |
| Dec 2011 | $16.61 M(+1067.5%) | $16.61 M(+1067.5%) |
| Dec 2010 | $1.42 M(-51.0%) | $1.42 M(-33.1%) |
| Jun 2006 | - | $2.13 M(-34.6%) |
| Mar 2006 | - | $3.25 M(+12.1%) |
| Dec 2005 | $2.90 M(-10.1%) | $2.90 M(+2.4%) |
| Sep 2005 | - | $2.84 M(-24.3%) |
| Jun 2005 | - | $3.75 M(+21.3%) |
| Mar 2005 | - | $3.09 M(-4.4%) |
| Dec 2004 | $3.23 M(-64.1%) | $3.23 M(-24.3%) |
| Sep 2004 | - | $4.27 M(-60.7%) |
| Jun 2004 | - | $10.85 M(+19.3%) |
| Mar 2004 | - | $9.10 M(+1.0%) |
| Dec 2003 | $9.01 M(+31.8%) | $9.01 M(+17.0%) |
| Sep 2003 | - | $7.70 M(-25.6%) |
| Jun 2003 | - | $10.34 M(+22.6%) |
| Mar 2003 | - | $8.44 M(+23.5%) |
| Dec 2002 | $6.83 M(+71.9%) | $6.83 M(+11.0%) |
| Sep 2002 | - | $6.15 M(+14.7%) |
| Jun 2002 | - | $5.37 M(+7.5%) |
| Mar 2002 | - | $4.99 M(+25.6%) |
| Dec 2001 | $3.97 M(+107.5%) | $3.97 M(+30.0%) |
| Sep 2001 | - | $3.06 M(+35.0%) |
| Jun 2001 | - | $2.26 M(-15.2%) |
| Mar 2001 | - | $2.67 M(+39.3%) |
| Dec 2000 | $1.92 M(-58.4%) | $1.92 M(-76.6%) |
| Sep 2000 | - | $8.18 M(+3.2%) |
| Jun 2000 | - | $7.93 M(+40.6%) |
| Mar 2000 | - | $5.64 M(+22.6%) |
| Dec 1999 | $4.60 M | $4.60 M |
FAQ
- What is Regeneron Pharmaceuticals annual inventory?
- What is the all time high annual inventory for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual inventory year-on-year change?
- What is Regeneron Pharmaceuticals quarterly inventory?
- What is the all time high quarterly inventory for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly inventory year-on-year change?
What is Regeneron Pharmaceuticals annual inventory?
The current annual inventory of REGN is $3.09 B
What is the all time high annual inventory for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual inventory is $3.09 B
What is Regeneron Pharmaceuticals annual inventory year-on-year change?
Over the past year, REGN annual inventory has changed by +$506.80 M (+19.64%)
What is Regeneron Pharmaceuticals quarterly inventory?
The current quarterly inventory of REGN is $3.09 B
What is the all time high quarterly inventory for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly inventory is $3.09 B
What is Regeneron Pharmaceuticals quarterly inventory year-on-year change?
Over the past year, REGN quarterly inventory has changed by +$506.80 M (+19.64%)